Model
Edge
Recursion Pharmaceuticals, Inc.
RXRX
Filing Type
8-K
Filing Date
11/4/2025
Updated
11/5/25, 4:37 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Financial Results, Changes in Board, Management or Compensation, Reg. FD
EX-99.1
Financial Results, Changes in Board, Management or Compensation, Reg. FD
EX-99.2
Financial Results, Changes in Board, Management or Compensation, Reg. FD
EX-99.3
Financial Results, Changes in Board, Management or Compensation, Reg. FD
EX-99.4
Financial Results, Changes in Board, Management or Compensation, Reg. FD
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC
GRAPHIC